RENAISSANCERE HOLDINGS LTD (RNR)

BMG7496G1033 - Common Stock

249.37  +1 (+0.4%)

After market: 249.37 0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to RNR. RNR was compared to 141 industry peers in the Insurance industry. While RNR belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. RNR is growing strongly while it also seems undervalued. This is an interesting combination This makes RNR very considerable for value and growth investing!



7

1. Profitability

1.1 Basic Checks

RNR had positive earnings in the past year.
RNR had a positive operating cash flow in the past year.
In multiple years RNR reported negative net income over the last 5 years.
Each year in the past 5 years RNR had a positive operating cash flow.

1.2 Ratios

RNR's Return On Assets of 7.42% is amongst the best of the industry. RNR outperforms 89.29% of its industry peers.
RNR has a Return On Equity of 34.84%. This is amongst the best in the industry. RNR outperforms 96.43% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.55%, RNR belongs to the top of the industry, outperforming 84.29% of the companies in the same industry.
Industry RankSector Rank
ROA 7.42%
ROE 34.84%
ROIC 6.55%
ROA(3y)0.62%
ROA(5y)1.37%
ROE(3y)1.53%
ROE(5y)5.19%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With an excellent Profit Margin value of 33.92%, RNR belongs to the best of the industry, outperforming 94.29% of the companies in the same industry.
RNR's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 37.46%, RNR belongs to the best of the industry, outperforming 95.00% of the companies in the same industry.
In the last couple of years the Operating Margin of RNR has grown nicely.
Industry RankSector Rank
OM 37.46%
PM (TTM) 33.92%
GM N/A
OM growth 3Y12.74%
OM growth 5Y13.83%
PM growth 3Y28.24%
PM growth 5Y25.78%
GM growth 3YN/A
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

RNR has more shares outstanding than it did 1 year ago.
The number of shares outstanding for RNR has been increased compared to 5 years ago.
Compared to 1 year ago, RNR has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.90, we must say that RNR is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.90, RNR belongs to the top of the industry, outperforming 81.43% of the companies in the same industry.
The Debt to FCF ratio of RNR is 0.50, which is an excellent value as it means it would take RNR, only 0.50 years of fcf income to pay off all of its debts.
RNR has a Debt to FCF ratio of 0.50. This is amongst the best in the industry. RNR outperforms 83.57% of its industry peers.
RNR has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
RNR's Debt to Equity ratio of 0.17 is fine compared to the rest of the industry. RNR outperforms 72.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 0.5
Altman-Z 0.9
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 0.55 indicates that RNR may have some problems paying its short term obligations.
RNR's Current ratio of 0.55 is fine compared to the rest of the industry. RNR outperforms 75.71% of its industry peers.
RNR has a Quick Ratio of 0.55. This is a bad value and indicates that RNR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of RNR (0.55) is better than 75.71% of its industry peers.
Industry RankSector Rank
Current Ratio 0.55
Quick Ratio 0.55

7

3. Growth

3.1 Past

RNR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 42.87%, which is quite impressive.
The Earnings Per Share has been growing by 32.22% on average over the past years. This is a very strong growth
RNR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.87%.
RNR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 32.27% yearly.
EPS 1Y (TTM)42.87%
EPS 3Y297.48%
EPS 5Y32.22%
EPS Q2Q%22.81%
Revenue 1Y (TTM)18.87%
Revenue growth 3Y17.76%
Revenue growth 5Y32.27%
Sales Q2Q%47.1%

3.2 Future

Based on estimates for the next years, RNR will show a small growth in Earnings Per Share. The EPS will grow by 0.58% on average per year.
Based on estimates for the next years, RNR will show a quite strong growth in Revenue. The Revenue will grow by 16.90% on average per year.
EPS Next Y13.16%
EPS Next 2Y-2.95%
EPS Next 3Y0.58%
EPS Next 5YN/A
Revenue Next Year49.08%
Revenue Next 2Y23.32%
Revenue Next 3Y16.9%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 5.35, which indicates a rather cheap valuation of RNR.
Compared to the rest of the industry, the Price/Earnings ratio of RNR indicates a somewhat cheap valuation: RNR is cheaper than 80.00% of the companies listed in the same industry.
RNR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.20.
RNR is valuated cheaply with a Price/Forward Earnings ratio of 7.15.
Based on the Price/Forward Earnings ratio, RNR is valued a bit cheaper than 78.57% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.73, RNR is valued rather cheaply.
Industry RankSector Rank
PE 5.35
Fwd PE 7.15

4.2 Price Multiples

RNR's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. RNR is cheaper than 80.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.32
EV/EBITDA N/A

4.3 Compensation for Growth

RNR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
RNR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.41
PEG (5Y)0.17
EPS Next 2Y-2.95%
EPS Next 3Y0.58%

4

5. Dividend

5.1 Amount

RNR has a yearly dividend return of 0.63%, which is pretty low.
Compared to an average industry Dividend Yield of 4.35, RNR is paying slightly less dividend.
With a Dividend Yield of 0.63, RNR pays less dividend than the S&P500 average, which is at 2.36.
Industry RankSector Rank
Dividend Yield 0.63%

5.2 History

The dividend of RNR has a limited annual growth rate of 2.53%.
RNR has paid a dividend for at least 10 years, which is a reliable track record.
RNR has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)2.53%
Div Incr Years26
Div Non Decr Years26

5.3 Sustainability

2.97% of the earnings are spent on dividend by RNR. This is a low number and sustainable payout ratio.
The dividend of RNR is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP2.97%
EPS Next 2Y-2.95%
EPS Next 3Y0.58%

RENAISSANCERE HOLDINGS LTD

NYSE:RNR (12/20/2024, 8:04:00 PM)

After market: 249.37 0 (0%)

249.37

+1 (+0.4%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)01-28 2025-01-28/amc
Inst Owners99.98%
Inst Owner Change0.35%
Ins Owners1.16%
Ins Owner Change-0.53%
Market Cap12.95B
Analysts74.44
Price Target302.11 (21.15%)
Short Float %2.69%
Short Ratio2.85
Dividend
Industry RankSector Rank
Dividend Yield 0.63%
Dividend Growth(5Y)2.53%
DP2.97%
Div Incr Years26
Div Non Decr Years26
Ex-Date12-13 2024-12-13 (0.39)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.06%
Min EPS beat(2)15.42%
Max EPS beat(2)30.69%
EPS beat(4)4
Avg EPS beat(4)29.08%
Min EPS beat(4)15.42%
Max EPS beat(4)42.03%
EPS beat(8)8
Avg EPS beat(8)23.7%
EPS beat(12)10
Avg EPS beat(12)12.78%
EPS beat(16)12
Avg EPS beat(16)4.47%
Revenue beat(2)0
Avg Revenue beat(2)-8.01%
Min Revenue beat(2)-14.49%
Max Revenue beat(2)-1.53%
Revenue beat(4)1
Avg Revenue beat(4)-2.48%
Min Revenue beat(4)-14.49%
Max Revenue beat(4)12.58%
Revenue beat(8)2
Avg Revenue beat(8)-1.45%
Revenue beat(12)2
Avg Revenue beat(12)-8.96%
Revenue beat(16)5
Avg Revenue beat(16)-0.54%
PT rev (1m)0.66%
PT rev (3m)9.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-36.49%
EPS NY rev (1m)2.67%
EPS NY rev (3m)7.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-10.26%
Revenue NY rev (1m)3.11%
Revenue NY rev (3m)3.91%
Valuation
Industry RankSector Rank
PE 5.35
Fwd PE 7.15
P/S 1.12
P/FCF 3.32
P/OCF 3.32
P/B 1.15
P/tB 1.23
EV/EBITDA N/A
EPS(TTM)46.59
EY18.68%
EPS(NY)34.9
Fwd EY13.99%
FCF(TTM)75.06
FCFY30.1%
OCF(TTM)75.06
OCFY30.1%
SpS222.32
BVpS216.45
TBVpS202.64
PEG (NY)0.41
PEG (5Y)0.17
Profitability
Industry RankSector Rank
ROA 7.42%
ROE 34.84%
ROCE 8.29%
ROIC 6.55%
ROICexc 6.76%
ROICexgc 7.88%
OM 37.46%
PM (TTM) 33.92%
GM N/A
FCFM 33.76%
ROA(3y)0.62%
ROA(5y)1.37%
ROE(3y)1.53%
ROE(5y)5.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y12.47%
ROICexcg growth 5Y22.51%
ROICexc growth 3Y12.17%
ROICexc growth 5Y23.5%
OM growth 3Y12.74%
OM growth 5Y13.83%
PM growth 3Y28.24%
PM growth 5Y25.78%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 0.5
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 99.54%
Current Ratio 0.55
Quick Ratio 0.55
Altman-Z 0.9
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.87%
EPS 3Y297.48%
EPS 5Y32.22%
EPS Q2Q%22.81%
EPS Next Y13.16%
EPS Next 2Y-2.95%
EPS Next 3Y0.58%
EPS Next 5YN/A
Revenue 1Y (TTM)18.87%
Revenue growth 3Y17.76%
Revenue growth 5Y32.27%
Sales Q2Q%47.1%
Revenue Next Year49.08%
Revenue Next 2Y23.32%
Revenue Next 3Y16.9%
Revenue Next 5YN/A
EBIT growth 1Y49.79%
EBIT growth 3Y32.76%
EBIT growth 5Y50.56%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y199.09%
FCF growth 3Y-1.37%
FCF growth 5Y9.37%
OCF growth 1Y199.09%
OCF growth 3Y-1.37%
OCF growth 5Y9.37%